FMNL1 and lymphoma: Additionally, FMNL1 is expressed in a variety of malignant tissues, while an antigenic peptide (FMNL1-PP2) derived from FMNL1 was experimentally shown to induce specific T cells to exert killing effects on tumors, including lymphomas (334).